Thrombocytosis after prophylactic administration of enoxaparin: Unexpected findings in a Polish prospective multicenter trial on the efficacy and safety of enoxaparin in the prevention of postoperative thromboembolism

International Angiology

Volumn 18, Issue 1, 1999, Pages 65-69

  Ziaja, K ^a,b   Simka, M ^a   Krupowies, A ^a   Dugaj, M ^a   Ludyga, T ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b 1St Dept Clin Gen and Vasc Surg   (Poland)

Author keywords

Blood platelets; Enoxaparin; Heparin; Heparin, low molecular weight; Platelet count; Thrombocytopenia; Thrombocytosis; Thromboembolism

Indexed keywords

ENOXAPARIN; HEPARIN;

ADULT; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CLINICAL TRIAL; GENERAL SURGERY; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NEOPLASM; ORTHOPEDIC SURGERY; POLAND; POSTOPERATIVE THROMBOSIS; PROPHYLAXIS; SUBCUTANEOUS DRUG ADMINISTRATION; THORAX SURGERY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOCYTOSIS;

ADOLESCENT; ADULT; ANTICOAGULANTS; ENOXAPARIN; HUMANS; MIDDLE AGED; ORTHOPEDIC PROCEDURES; PLATELET COUNT; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; THORACIC SURGICAL PROCEDURES; THROMBOCYTOSIS; THROMBOEMBOLISM;

EID: 0032980197     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Carter CA, Skoutakis VA, Spirp TE, West ME, Tooms RE, Joe RH et al. Enoxaparin: the low-molecular-weight heparin for prevention of postoperative thromboembolic complications. Ann Pharmacother 1993;27:1223.
2. Nicolaides AN, Bergquist D, Hull R. Prevention of venous thromboembolism. International consensus statement (guidelines according to scientific evidence). Int Angiol 1997;16(1):3-38.
3. Fareed J, Hoppensteadt DA, Walenga JM. Current perspectives on low molecular weight heparins. Semin Thromb Hemost 1993;19(Suppl 1):1.
4. Hoppensteadt DE, Jeske W, Ahsan A, Walenga J, Fareed J. Biochemical and pharmacological profile of defined molecular weight fractions of heparin. Semin Thromb Hemost 1993;19(Suppl 1):12.
5. Dunn F, Soria C, Thomaidis A, Dupuis E, Bellucci S, Soria J. Interactions of platelets with standard heparin and low molecular weight fractions. Nouv Rev Fr Hematol 1984;26:249.
6. Messmore HL, Griffin B, Fareed J, Coyne E, Seghatchian J. In vitro studies of the interaction of heparin, low molecular weight heparin and heparinoids with platelets. Ann NY Acad Sci 1989;556:217.
7. Salzman EW, Rosenberg RD, Smith MH, Lindon JN, Favreau L. Effect of heparin and heparin fractions on platelet aggregation. J Clin Invest 1980;65:64.
8. Brace LD, Fareed J. Heparin-induced platelet activation: dose/response relationships for a low molecular weight derivative (PK 10169) and its subtractions. Thromb Haemost 1985;54:308.
9. Soria J, Mirshahi MC, Neuhart E, Steg PG, Combe S, Soria C. Reduced effect of enoxaparin compared to unfractionated heparin on platelet retention to fibrin clot. Thromb Haemost 1991;65:1301.
10. Vermylen JG. Effect of heparin and low molecular weight heparins on platelets. Semin Thromb Hemost 1993;19(Suppl 1):20.
11. Haas S, Flosbach CW. Prevention of postoperative thromboembolism in general surgery with enoxaparin: preliminary findings. Acta Chir Scand 1990;(Suppl 556):96.
12. Haas S, Flosbach CW. Prevention of postoperative thromboembolism with enoxaparin in general surgery: a German multicenter trial. Semin Thromb Hemost 1993;19(Suppl 1):164.
13. Williams E. Thrombocytosis associated with low-molecular-weight heparin. Ann Intern Med 1997; 126:742.
14. Rizzieri DA, Gockerman JP. Thrombocytosis associated with low-molecular-weight heparin. Reply Ann Intern Med 1997;126:742-3.
15. Anderson KC, Ness PM. Scientific basis of transfusion medicine. Implications for clinical practice. Philadelphia: Saunders Company, 1994.
16. Kretschmer V, Stangel W. Transfusionsmedizin aktuell - Infektionen, Thrombozyten, Granulozyten. München: Karger, 1986.
17. Mollison PL, Engelfriet CP, Contreras M. Blood transfusion in clinical medicine. Oxford: Blackwell Scientific Publications, 1987.
18. Petz LD, Swisher SN. Clinical practice of blood transfusion. New York: Churchill Livingstone, 1981.